Tokyo - Delayed Quote JPY
GNI Group Ltd. (2160.T)
2,200.00
+10.00
+(0.46%)
At close: 3:30:00 PM GMT+9
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 2 |
| Avg. Estimate | -- | -- | 48.71B | 51.87B |
| Low Estimate | -- | -- | 46B | 44.93B |
| High Estimate | -- | -- | 52.14B | 58.82B |
| Year Ago Sales | -- | -- | 24M | 48.71B |
| Sales Growth (year/est) | -- | -- | 202,873.61% | 6.49% |
Earnings History
| Currency in JPY | 3/31/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|
| EPS Est. | -- | 13.04 | 113.19 |
| EPS Actual | 29.17 | 19.51 | -6.57 |
| Difference | -- | 6.47 | -119.76 |
| Surprise % | -- | 49.62% | -105.80% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2160.T | -- | -- | -- | -- |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Related Tickers
36X.F Ascentage Pharma Group International
5.05
+6.09%
AAPG Ascentage Pharma Group Internat
21.60
+12.97%
GYRE Gyre Therapeutics, Inc.
8.64
+2.86%
PULM Pulmatrix, Inc.
6.31
+2.44%
GLYC GlycoMimetics, Inc.
0.2265
+3.38%
NERV Minerva Neurosciences, Inc.
1.7100
+2.40%
IMAB I-Mab
0.8304
-2.88%
IGMS IGM Biosciences, Inc.
1.4600
+14.06%
ERAS Erasca, Inc.
1.3800
+11.29%
OLMA Olema Pharmaceuticals, Inc.
4.9600
+4.42%